Analgesic clinical trials often fail, even when we know the drugs work. Join Lynn King and Karen Kesler as they share real-world solutions for trial design, execution, and analysis that will increase patient retention, minimize missing data, and help you successfully navigate FDA’s new paradigm for clinical trials in pain.
Senior Statistical Scientist
Assistant Vice President, Operations
- What Non-statisticians Need to Know about Statistics in Clinical Trials
- Using FDA’s Draft Guidance on Risk-Based Monitoring to Improve Clinical Data Quality
- Targeted Product Development: Personalized Medicine versus Orphan Product Development
- PDUFA V: What you need to know about the upcoming Prescription Drug User Fee Act